YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing Meeting Abstract


Authors: Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; Spraggon, L.; Lovly, C. M.; Kris, M. G.; Yu, H. A.; Riely, G. J.; Varmus, H.; Politi, K. A.; Ladanyi, M.
Abstract Title: YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 459s
Language: English
ACCESSION: WOS:000411932202105
DOI: 10.1200/JCO.2017.35.15_suppl.9043
PROVIDER: wos
Notes: Meeting Abstract: 9043 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Helena Alexandra Yu
    281 Yu
  2. Marc Ladanyi
    1326 Ladanyi
  3. Gregory J Riely
    599 Riely
  4. Lu Wang
    147 Wang
  5. Achim Jungbluth
    454 Jungbluth
  6. Pang-Dian Fan
    15 Fan
  7. Mark Kris
    869 Kris
  8. Harold Varmus
    96 Varmus
  9. Emmet John Jordan
    47 Jordan